References
- Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. IARC: IARC Scientific Publications No. 155, Lyon 2002; VIII
- Berrino F, Capocaccia R, Coleman MP, Estève J, Gatta G, Hakulinen T, et al. Survival of cancer patients in Europe: The EUROCARE 3 study. Ann Oncol 2003; 14(Suppl 5)1–155
- World Health Organisation (1975) . International classification of diseases. 9th ed. Geneva: .
- World Health Organisation. International statistical classification of diseases and related health problems. 10th revision, Vols 1–3. 1992–1994. 3rd ed., Geneva: 1994.
- European Network of Cancer Registries. Eurocim version 4.0. European incidence database V2.3, 730 entity dictionary Lyon. 2001.
- Barnes L. Intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses. Am J Surg Pathol 1986; 10: 192–202
- Capocaccia R, Gatta G, Roazzi P, Carrani E, Santaquilani M, De Angelis R, et al. The EUROCARE-3 database: Methodology of data collection, standardisation, quality control and statistical analysis. Ann Oncol 2003; 14(Suppl 5)14–27
- Jiong, L, Berrino, F, Coebergh, JW and the EUROCARE Working Group. Variation in survival for adults with nasopharyngeal cancer in Europe, 1978-1989. Eur J Cancer 1998;34:2162–6.
- Berrino, F, Gatta, G. and EUROCARE Working Group. Variation in survival of patients with head and neck cancer in Europe by the site of origin of the tumours. Eur J Cancer 1998;34:2154–61.
- World Health Organisation. International classification of diseases for oncology (ICD-O). 2nd ed. Geneva: 1990.
- Berg, JM. Morphological classification of human cancer, In:D Schottenfeld, JF Fraumeni. Cancer epidemiology and prevention, 2nd ed. New York: OUP; 1996; 28–44.
- Coleman MP, Gatta G, Verdecchia A, Estève J, Sant M, Storm H, et al. EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century. Ann Oncol 2003; 14(Suppl 5)128–49
- Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38: 933–42
- Micheli A, Baili P, Quinn M, Mugno E, Capocaccia R, Grosclaude P. Life expectancy and cancer survival in the EUROCARE-3 cancer registry areas. Ann Oncol 2003; 14(Suppl 5)28–40
- Hakulinen T, Tenkanen L. Regression analysis of relative survival rates. Applied Stat 1987; 19: 197–207
- Surveillance Research Program, National Cancer Institute SEER*Stat software, , www.seer.cancer.gov/seerstat. version 5.2.2.
- StataCorp. 2001. Stata Statistical Software: Release 7.0. College Station, TX: Stata Corporation.
- Stoll D, Bebear JP, Truilhe Y, Darrouzet V, David N. Ethmoid adenocarcinoma: Retrospective study of 76 patients. Rev Laryngol Otol Rhinol (Bord) 2001; 122: 21–9
- Jiang G-L, Morrison WH, Garden AS, Geara F, Callender D, Goepfert H, et al. Ethmoid sinus carcinoma: Natural history and treatment results. Radiother Oncol 1998; 49: 21–7
- Dulguerov P, Jacobsen MS, Allal AS, Lehmann W, Calcaterra T, et al. Nasal and paranasal sinus carcinoma: Are we making progress?. Cancer 2001; 92: 3012–29
- Grau C, Jakobsen H, Harbo G, Svane-Knudsen V, Wedervang K, Larsen SK, et al. Sino-nasal cancer in Denmark 1982-1991. A nationwide survey. Acta Oncol 2001; 40: 19–23
- Bhattacharyya N. Factors predicting survival for cancer of the ethmoid sinus. Am J Rhinol 2002; 16: 281–6
- Weymuller EA, Reardon EJ, Nash D. A comparison of treatment modalities in carcinoma of maxillary antrum. Arch Otorhinolaryngol 1980; 106: 625–9
- Engzell U, Englund A, Westerholm P. Nasal cancer associated with occupational exposure to organic dust. Acta Otolaryngol 1978; 86: 437–42
- Cecchi F, Buiatti E, Kriebel D. Adenocarcinoma of the nose and paranasal sinuses in shoemakers and woodworkers in the province of Florence, Italy. Br J Ind Med 1980; 37: 222–5